Bo Ahrén Selected Research

Bo Ahrén Research Topics

Disease

81	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2002
51	Insulin Resistance 07/2021 - 02/2002
25	Hypoglycemia (Reactive Hypoglycemia) 07/2021 - 01/2002
20	Body Weight (Weight, Body) 09/2017 - 01/2003
19	Glucose Intolerance 01/2021 - 02/2002
15	Hyperglycemia 07/2021 - 02/2002
13	Obesity 09/2015 - 01/2002
7	Nausea 01/2018 - 09/2013
7	Hyperinsulinism (Hyperinsulinemia) 11/2016 - 09/2003
6	Weight Loss (Weight Reduction) 01/2018 - 03/2003
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016 - 01/2002
4	Vomiting 01/2018 - 09/2013
4	Weight Gain 09/2017 - 01/2013
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2008 - 09/2003
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2006 - 10/2004
3	Neoplasms (Cancer) 03/2006 - 02/2002
3	Dyslipidemias (Dyslipidemia) 02/2005 - 10/2004
2	Injection Site Reaction 04/2017 - 08/2014
2	Inflammation (Inflammations) 07/2014 - 05/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2006 - 10/2004
2	Atherosclerosis 05/2005 - 02/2002
2	Hyperphagia (Overeating) 02/2005 - 01/2005
2	Myocardial Infarction 04/2004 - 02/2004
1	Pancreatitis 04/2017
1	Ketosis 10/2016
1	Diabetes Complications 08/2015

Drug/Important Bio-Agent (IBA)

75	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 02/2002
58	Insulin (Novolin)FDA Link 07/2021 - 01/2002
36	Glucagon (Glukagon)FDA Link 07/2021 - 01/2002
25	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2019 - 05/2002
22	Metformin (Glucophage)FDA LinkGeneric 07/2021 - 12/2004
18	Hormones (Hormone)IBA 01/2020 - 01/2003
18	IncretinsIBA 01/2020 - 10/2003
13	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 12/2004
10	LeptinIBA 10/2008 - 01/2003
9	VildagliptinIBA 01/2018 - 08/2005
8	Glucagon-Like Peptide-1 ReceptorIBA 01/2021 - 02/2008
7	Sitagliptin Phosphate (Januvia)FDA Link 01/2018 - 03/2010
7	Peptides (Polypeptides)IBA 07/2014 - 10/2003
6	ThiazolidinedionesIBA 07/2021 - 12/2008
6	Pharmaceutical PreparationsIBA 03/2019 - 12/2007
6	lixisenatideIBA 01/2017 - 09/2013
6	Arginine (L-Arginine)FDA Link 03/2007 - 01/2002
5	Liraglutide FDA Link 12/2019 - 10/2015
5	Hypoglycemic Agents (Hypoglycemics)IBA 03/2019 - 09/2004
5	rGLP-1 proteinIBA 09/2017 - 08/2014
5	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2013 - 05/2002
4	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2019 - 05/2011
4	glimepiride (Amarel)FDA LinkGeneric 09/2017 - 04/2010
4	Glucagon Receptors (Glucagon Receptor)IBA 03/2016 - 01/2014
4	Blood Glucose (Blood Sugar)IBA 02/2016 - 09/2004
4	Growth Hormone (Somatotropin)IBA 05/2006 - 07/2003
3	Insulin Glargine (Lantus)FDA Link 01/2018 - 08/2014
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2016 - 04/2009
3	LipidsIBA 10/2015 - 02/2004
3	Proteins (Proteins, Gene)FDA Link 09/2014 - 09/2003
3	Insulin-Like Growth Factor I (IGF-1)IBA 09/2013 - 02/2006
3	EnzymesIBA 04/2007 - 06/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 03/2007 - 04/2004
3	Biological ProductsIBA 05/2006 - 10/2004
3	Triglycerides (Triacylglycerol)IBA 12/2005 - 04/2004
2	semaglutideIBA 01/2018 - 01/2017
2	(L)-Isomer Glucose (L-Glucose)IBA 01/2018 - 02/2016
2	Exenatide (Byetta)FDA Link 01/2018 - 02/2008
2	Insulin Lispro (Humalog)FDA Link 08/2017 - 08/2014
2	LinagliptinIBA 01/2017 - 02/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 02/2016 - 07/2003
2	fibroblast growth factor 21IBA 10/2015 - 01/2014
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 07/2014 - 11/2008
2	Drinking WaterIBA 10/2010 - 01/2005
2	Interleukin-6 (Interleukin 6)IBA 06/2010 - 01/2002
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 05/2009 - 12/2007
2	Hydrocortisone (Cortisol)FDA LinkGeneric 04/2007 - 07/2003
2	Capsaicin (Zostrix)FDA Link 01/2007 - 12/2005
2	C-Reactive ProteinIBA 11/2006 - 12/2005
2	Type 3 Cyclic Nucleotide PhosphodiesterasesIBA 06/2006 - 04/2004
2	AdiponectinIBA 02/2006 - 08/2004
2	Biomarkers (Surrogate Marker)IBA 05/2005 - 10/2004
2	Lipoproteins (Lipoprotein)IBA 02/2005 - 02/2004
2	Messenger RNA (mRNA)IBA 09/2004 - 09/2003
2	GhrelinIBA 08/2004 - 03/2003
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 09/2003 - 05/2003
2	Amyloid (Amyloid Fibrils)IBA 09/2003 - 11/2002
2	Carbachol (Carbastat)FDA Link 10/2002 - 01/2002
2	Deoxyglucose (2 Deoxy D glucose)IBA 10/2002 - 01/2002
2	AlloxanIBA 02/2002 - 01/2002
1	SodiumIBA 07/2021
1	gastric inhibitory polypeptide receptorIBA 01/2021
1	dapagliflozinIBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	Pioglitazone (Actos)FDA Link 09/2017
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	Nonesterified Fatty Acids (NEFA)IBA 10/2015
1	KetonesIBA 10/2015

Therapy/Procedure

25	Therapeutics 07/2021 - 12/2004
11	Glycemic Control 02/2016 - 12/2004
4	Injections 12/2019 - 09/2013
4	Paleolithic Diet 11/2010 - 12/2005
2	Radiotherapy 05/2006 - 10/2004
2	Bariatric Surgery 07/2003 - 03/2003